Value Sense
BHG
Bright Health Group, Inc. (BHG)
Last Price$8.20.0%
Market Cap$65.5M
Intrinsic value score
N/A
Great
Intrinsic value
N/A
DCF value - N/A Relative value - N/A
Undervalued
N/A
LTM P/E
N/A
Peer set median 16.5x
Discount rate
N/A
BHG
is 463.3% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

BHG Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Feb 20, 2024 BHG Relative Value is $46.2, which is undervalued by 462.4%, compared to current share price of $8.2.
DCF Value vs Current Share Price
As of Feb 20, 2024 BHG DCF Value is N/A, which is undervalued by N/A, compared to current share price of $8.2.
Methodology
Price per share, $
BHG
Intrinsic value$46.2
Undervalued by463.3%
Current share price
8.2
Relative value
46.2
DCF value
not available

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

BHG Historical Intrinsic Value

Crunching data... Almost there!

BHG vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
463.3%
(51.9%)
86.2%
(103.4%)
Median Peer Set
8.7%
(11.9%)
1.6%
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
(47.0%)
27.2%
(4.8%)
(8.1%)
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
(45.3%)
(41.5%)
(31.3%)
(10.5%)
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
37.0%
19.3%
9.2%
2.9%
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
57.0%
56.5%
N/A
0.3%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
124.2%
8.9%
(35.7%)
3.6%
Elevance Health Inc. logo
Elevance Health Inc.ELV
153.3%
3.2%
(0.0%)
3.4%
Cigna Corporation logo
Cigna CorporationCI
202.7%
8.4%
(18.9%)
2.6%
Humana Inc. logo
Humana Inc.HUM
205.0%
10.7%
(50.1%)
1.0%
CVS Health Corporation logo
CVS Health CorporationCVS
220.8%
4.2%
(43.6%)
1.2%
Centene Corporation logo
Centene CorporationCNC
2,301.3%
5.9%
27.4%
2.0%

Explore more intrinsic value tools hub for BHG

DCF value calculator
Reverse DCF
Peter Lynch charts
Relative Value
Earnings growth model
Peter Lynch Fair Value
Margin of safety
Ben Graham Fair Value
Earnings Power Value
Discount rate

FAQ

What is Bright Health Group, Inc. intrinsic value?

As of Feb 20, 2024, Bright Health Group, Inc. Intrinsic Value is $46.2. This suggests it may be undervalued by 463.3% compared to its current price of around $8.2.

What is Bright Health Group, Inc. DCF (discounted cash flow) valuation?

As of Feb 20, 2024, Bright Health Group, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $8.2, using a discount rate of 3.9% and terminal growth rate of 3.0%.

Is Bright Health Group, Inc. overvalued or undervalued?

Bright Health Group, Inc. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $46.2, compared to a market price of around $8.2. This suggests a potential undervaluation of 463.3%.